8306
R.I. Kureshy et al. / Tetrahedron 67 (2011) 8300e8307
resulting suspension was stirred for 6 h and the reaction mixture
was processed as mentioned above to yield the complexes 6. (Data
is given in Supplementary data).
monitored on TLC. At the end of the reaction the solvent was
completely removed and the residue was repeatedly extracted with
n-hexane/diethyl ether (70:30, 5ꢃ6¼30 mL). The residue left was
the catalyst and the organic layer contained the products trans-b-
4.7.6. Synthesis of chiral macrocyclic Cr(III) salen complex
(7). Complex 7 was prepared by the reaction of methanolic solu-
tion of dimeric complex 1 (0.500 mg, 0.397 mmol, 20 mL) with an
aqueous solution (0.275 mg, 0.8 mmol, 0.4 mL) of AgSbF6. The
resulting suspension was stirred for 6 h and centrifuged. The sol-
vent removal from the supernatant yielded the complex 7. (Data is
given in Supplementary data).
amino alcohol (1S,2R)-11a and the unreacted epoxides (2R,3R)-9,
recovery of which was done by column chromatography in quan-
titative yields using hexaneþethyl acetate (9:1) as an eluent.
4.11. Recycling of the catalyst 1
Catalyst recycle experiments were carried out at the 5 mmol
scale of the substrates trans-stilbene oxide 9 (0.981 g) and aniline
10a (0.227 mL) with 1 mol % of the catalyst 1 (0.031 g) under the
above optimized reaction conditions. At the end of the catalytic run
(checked on TLC) the solvent was completely removed under re-
duced pressure. The residue was extracted with n-hexane/diethyl
ether (70:30) (3ꢃ5 mL) and the remaining solid (catalyst) was
further washed with hexane (2ꢃ5 mL). The recovered solid was
dried under the reduced pressure for 1e2 h and was used as re-
covered catalyst for recycle experiments of AKR reaction of trans-
stilbene oxide. The products aminoalcohol and enantioenriched
epoxide were obtained in the manner described in preceding par-
agraph. Similar scale and procedure was followed for the catalyst 1
recycle experiment conducted for the ARO of meso-stilbene oxide
16 with aniline 10a.
4.7.7. Synthesis of chiral macrocyclic Cr(III) salen complex (8). To
prepare complex 8, a solution of complex 1 (0.500 mg, 0.397 mmol)
in methanol containing 5% water (20 mL), which was passed slowly
over a bed (1 cmꢃ10 cm) of KBrover 3 h. The solvent was then
removed completely and the residue was dried in a desiccator to
get the complex
8 in quantitative yield (Data is given in
Supplementary data).
4.8. Typical procedure for the AKR of racemic trans-epoxides
In a small vial equipped with a magnetic stirring bar, the chiral
macrocyclic Cr(III) salen complexes 1e8 (1 mol % based on mono-
meric unit) were taken in DCMþMeOH (9:1, 0.4 mL) and the
resulting solution was stirred for 5 min followed by the addition of
an appropriate epoxide (0.2 mmol). The resulting mass was stirred
for 10 min followed by the addition of desired aniline as a nucleo-
phile (0.1 mmol) at room temperature. The progress of the catalytic
reaction was monitored on TLC. At the end of the reaction the re-
action mixture was repeatedly extracted with n-hexane/diethyl
Acknowledgements
K.J.P. and R.I.K. are thankful to CSIR-SRF, DST, and CSIR Network
Project on Catalysis for financial assistance. The authors also
thankful to ‘Analytical Science Discipline’ for providing in-
strumental facilities.
ether (70:30, 2ꢃ5 mL). The product trans-
b-amino alcohols 11aeg,
14aeg, 15aeg and the unreacted epoxides (2R,3R)-9, (2R,3R)-12,
(2S,3S)-13 were recovered by column chromatography. The re-
covered catalyst was dried under vacuum and stored in a desiccator
for its use in the subsequent catalytic runs.
Supplementary data
Characterization data of chiral macrocyclic ligand, its precursor
and chiral Cr(III) salen complexes including 1H, 13C NMR, FT-IR,
CHN, ICP, mp, Optical rotation, ESI-MS, MALDI-TOF, and HPLC pro-
file. Supplementary data associated with this article can be found,
4.9. Typical experimental procedure for ring opening of
meso-epoxides
To a 5 mL round bottom flask equipped with rubber septum and
a magnetic stirring bar, the chiral macrocyclic Cr(III) salen complex
1 (0.5 mol %) was taken in DCMþMeOH (9:1, 0.4 mL) and the
resulting solution was stirred for 5 min followed by the addition of
an appropriate meso-epoxide (0.2 mmol). Subsequently, after
20 min, aniline (0.2 mmol) was added and the reaction mixture was
further allowed to stir for the specified time at room temperature.
The progress of the reaction was checked on TLC using hexane/ethyl
acetate (8/2) as mobile phase. After the completion of the reaction,
solvent was removed under vacuum and the product was purified
by column chromatography using silica gel 100e200 mesh as sta-
tionary phase and hexane/ethyl acetate (8:2) as mobile phase. All
the products were characterized by appropriate spectroscopic
techniques, microanalysis, LCMS, and optical rotation, which were
found to be in consonance with the reported values.5c,5d,6a,6b
References and notes
1. (a) Hashiguchi, S.; Kawada, A.; Natsugari, H. J. Chem. Soc., Perkin Trans. 1 1991,
2435e2444; (b) Wang, Y. F.; Izawa, T.; Kobayashi, S.; Ohno, M. J. Am. Chem. Soc.
1982, 104, 6465e6466; (c) Knapp, S. Chem. Rev. 1995, 95, 1859e1876; (d) Horri,
S.; Fukase, H.; Matsuo, T.; Kameda, Y.; Asano, N.; Matsui, K. J. Med. Chem. 1986,
29, 1038e1046; (e) Main, B. G.; Tucker, H. In Medicinal Chemistry: The role of
Organic Chemistry in Drug Research of Beta Blockers; Roberts, S. M., Price, B. J.,
Eds.; Academic: London, 1985; (f) Howe, R.; Crowther, A. F.; Stephenson, J. S.;
Rao, B. S.; Smith, L. H. J. Med. Chem. 1968, 11, 1000e1008; (g) Crowther, A. F.;
Smith, L. H. J. Med. Chem. 1968, 11, 1009e1013; (h) Howe, R.; Rao, B. S. J. Med.
Chem. 1968, 11, 1118e1121 and references cited therein.
2. (a) Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96, 835e875; (b) Eliel,
E. L.; He, X. C. J. Org. Chem. 1990, 55, 2114e2119; (c) Hayashi, Y.; Rhode, J. J.;
Corey, E. J. J. Am. Chem. Soc. 1996, 118, 5502e5503; (d) Senanayake, C. H.; Fang,
K.; Grover, P.; Bakale, R. P.; Vandenbossche, C. P.; Wald, S. A. Tetrahedron Lett.
1999, 40, 819e822.
3. (a) Li, G.; Chang, H. T.; Sharpless, K. B. Angew. Chem., Int. Ed. 1996, 35, 451e454;
(b) O’Brien, P. Angew. Chem., Int. Ed. 1999, 38, 326e329; (c) List, B. J. Am. Chem.
Soc. 2000, 122, 9336e9337; (d) Cordova, A.; Notz, W.; Zhong, G.; Betancort, J.
M.; Barbas, C. F., III. J. Am. Chem. Soc. 2002, 124, 1842e1843; (e) Trost, B. M.;
Terrell, L. R. J. Am. Chem. Soc. 2003, 125, 338e339.
ꢀ
4.10. Typical experimental procedure for 10 mmol scale of
trans-stilbene oxide with aniline
4. (a) Arai, K.; Salter, M. M.; Yamashita, Y.; Kobayashi, S. Angew. Chem., Int. Ed. 2007, 46,
955e957; (b) Arai, K.; Lucarini, S.; Salter, M. M.; Ohta, K.; Yamashita, Y.; Kobayashi,
S. J. Am. Chem. Soc. 2007, 129, 8103e8111; (c) Tanaka, K.; Oda, S.; Shiro, M. Chem.
Commun. 2008, 820e822; (d) Sekine, A.; Ohshima, T.; Shibasaki, M. Tetrahedron
2002, 58, 75e82; (e) Hou, X. L.; Wu, J.; Dai, L.; Xia, J. X. L.; Tang, M. H. Tetrahedron:
Asymmetry 1998, 9, 1747e1752; (f) Inaba, T.; Birchler, A. G.; Yamada, Y.; Sagawa, S.;
Yokota, K.; Ando, K.; Uchida, U. J. Org. Chem. 1998, 22, 7582e7583; (g) Inaba, T.;
Yamada, Y.; Abe, H.; Sagawa, S.; Cho, H. J. Org. Chem. 2000, 6, 1623e1628.
In a 25 mL vial equipped with a magnetic stirring bar, the chiral
macrocyclic Cr(III) salen complex 1 (0.063 g, 1 mol % based on
monomeric unit) was taken in DCMþMeOH (9:1, 4 mL) and the
resulting solution was stirred for 5 min followed by the addition of
trans-stilbene oxide (1.962 g, 10 mmol). The resulting mass was
stirred for 10 min to which aniline (0.455 mL, 5 mmol) was added at
room temperature. The progress of the catalytic reaction was
ꢀ
5. (a) Fu, X. L.; Wu, S. H. Synth. Commun. 1997, 27, 1677e1683; (b) Carree, F.; Gil, R.;
ꢀ
Collin, J. Tetrahedron Lett. 2004, 45, 7749e7751; (c) Carree, F.; Gil, R.; Collin, J.